#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyloidosis Primary immunodeficiency syndrome Polycystic liver disease Cholangitis sclerosing Haemophilia A with anti factor VIII Alport's syndrome Mantle cell lymphoma stage IV Neurotrophic keratopathy Small intestine adenocarcinoma CDKL5 deficiency disorder Pancreatic carcinoma Metastases to central nervous system Neuroblastoma recurrent Oesophageal squamous cell carcinoma stage II Haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Diagnostics Waldenstrom’s macroglobulinaemia – Diagnostics Castleman’s disease – Trials in Disease Cystic fibrosis – Treatment Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Retinitis pigmentosa – Trials in Disease Haemophilia A with anti factor VIII – Treatment Loeys-Dietz syndrome – Basic Information Piriformis syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cabotegravir Micronised Spironolactone Lenomorelin Ladarixin Pantothenate Sodium Patiromer Ublituximab ICEF15 Atezolizumab Molidustat Sodium Lactose Monohydrate SKB410 Umeclidinium Tx200-Tr101 Belzupacap Sarotalocan Ttf-Ngr Hydroxycarbamide Pimavanserin Tartrate Perflutren Cefaclor More therapies…

    Learn about Your Condition

    Pyrexia Univentricular heart Device related infection Colorectal cancer stage IV Seasonal allergy Hypoalbuminaemia Klinefelter's syndrome Left ventricular dysfunction Bladder cancer recurrent Hypersomnia Malignant melanoma Hepatitis alcoholic Nasopharyngeal cancer Progressive multiple sclerosis Rheumatic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Partial seizures

  • Study of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • HUPERZINE A
    Bulgaria Hungary Poland

  • Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

    Recruiting

    3 1 1
    Investigated Diseases:
    • Generalised tonic-clonic seizure
    • Partial seizures
    Investigated Drugs:
    • Prax-628
    • VORMATRIGINE
    Germany Italy Poland Spain

  • Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

    Recruiting

    2 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia France Hungary +3

  • Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

    Recruiting

    2 1 1
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia Denmark Finland +12

  • Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +10

  • Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

    Recruiting

    3 1
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +8
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!